A BSTR ACT
Given the results of experimental studies, occupational or environmental exposures to manufactured nanoparticles or to unintentionally produced ultrafine particles may result in health effects or diseases in humans. In this review, we synthesize published data of experimental studies on the distribution of inhaled nanoparticles and the first case reports to discuss the potential usefulness of their biological monitoring for clinical purposes. Toxicokinetic studies suggest that nanoparticles may be absorbed predominantly by respiratory and oral routes with possible systemic translocation, leading to accumulation in the peripheral organs or excretion in feces or urine. Some methods used in these studies may be applied successfully in retrospective evaluation of exposure or in follow-up of occupational exposure in the workplace. Biological monitoring of nanoparticles should be based on imaging methods that are essential to confirm their presence and to characterize them in tissue associated with analytical quantitative methods. The first case reports reviewed emphasize the urgent need for the development of standardized procedures for the preparation and analysis of biological samples with a view to characterizing and quantifying nanoparticles.
IN TROD UCTION Nano-objects are defined by the International Organization for Standardization as material with one, two, or three external dimensions in the size range 1-100 nm. This definition includes nanofibers (nano-objects with two similar external dimensions in the nanoscale) and nanoparticles (NP; nano-objects with all three external dimensions in the nanoscale; ISO, 2011) . However, toxicological and biokinetic properties specific to nanomaterials can be found for particles above 100 nm (Kendall et al., 2012) and probably up to 500 nm . NP can be intentionally manufactured or unintentionally produced [such as combustion-derived ultrafine particles, that differ from the former by their polydispersed diameter and complex chemical composition (Bakand et al., 2012) ]. For these two types of NP, similar effects and toxicological mechanisms have been reported (Oberdörster et al., 2004) and similar tools may be used to characterize and quantify them in the workplace or inbiological samples. Thus, for the sake of clarity, the term 'nanoparticles' is used here to refer to nanosized particles independently of their origins or aggregation status. Owing to an exponential increased reactive surface, their chemical composition or their ability to adsorb toxins, the particular toxicity of NP has been largely demonstrated in experimental studies, including respiratory effects (Andujar et al., 2011) and extra-pulmonary effects on cardiovascular, neurological, and immune systems (Ostiguy et al., 2006) . In humans, the toxicity of ultrafine fractions of particulate matter (atmospheric pollution) has been suggested in epidemiological studies demonstrating a greater incidence of pulmonary diseases (pneumonia, asthma, chronic obstructive pulmonary disease, cancer) or cardiovascular morbidity and mortality (Ostiguy et al., 2006; Yang et al., 2008; Kendall et al., 2012) . It remains unclear whether these extra-pulmonary effects are related to extra-pulmonary translocation (Kendall et al., 2012; Landsiedel et al., 2012) . For these reasons, the toxicokinetics of NP is a major subject of toxicological studies, especially given the intense development of nanomedicine (Card et al., 2008; Arvizo et al., 2010; Sa et al., 2012) . These studies provide methods and results that are potentially useful in the development of biological monitoring of environmental or workplace exposure to NP and in the diagnosis of diseases potentially related to these exposures.
The aim of this article is to review the methods related to the toxicokinetics of inhaled NP through biological barriers in animal and in human, to synthesize their results and to discuss the possibilities of developing biological monitoring of NP.
WH AT A R E THE NEEDS?
The exponential increase in the production and commercialization of nano-based products is a potential source of occupational or environmental exposure via respiratory, dermal, and oral routes. Inhalation is the most widely documented and probably the most significant exposure route for NP (Schmid et al., 2009 ). These exposures have been suspected to cause adverse effects such as pulmonary effects (Khatri et al., 2013; Wu et al., 2014) , pulmonary diseases (Song et al., 2009; Phillips et al., 2010) , and allergic diseases ( Journeay et al., 2014) . Other potential sources of exposure in humans are the various applications of NP in biomedicine such as superparamagnetic iron oxide NP, dendrimers, mesoporous silica NP, gold NP and carbon nanotubes (CNT; Kunzmann et al., 2011) . Occupational activities are also a possible source of exposure to unintentional NP. Welding is an example of human exposure to metallic NP such as manganese in a range of concentrations proven to induce an inflammatory response in inhalation studies in rodents (Elder et al., 2006) . Hereafter some case reports are summarized in which clinicians tried to characterize NP in human tissues.
One patient died from a respiratory distress syndrome after an acute exposure to nickel NP while spraying nickel in a metal arc process. High levels of nickel were found in his urine and kidney and NP less than 25 nm in diameter were detected in his alveolar macrophages (Rendall et al., 1994; Phillips et al., 2010) . In two patients who died from pneumoconiosis after aluminum welding, scanning electron microscopy (SEM) revealed concentrations of aluminum particles from 8.5 to 11.2 billion particles per cm 3 of lung tissue. Transmission electron microscopy (TEM) examination revealed that the particles were mostly aggregates of particles as small as 10 nm (Hull et al., 2002) . Seven young female Chinese workers suffered from shortness of breath, pleural effusion, and progressive pulmonary fibrosis after several months of chronic exposure to polyacrylic ester spray-painting. NP were found by TEM in their chest fluid, pulmonary epithelial, and mesothelial cells suggesting regional pulmonary translocation. Although chemical characterization was not performed, polyacrylate NP were suspected to have caused the diseases (Song et al., 2009) . However, owing to limitations in the assessment of occupational exposure and a lack of information on the chemical composition of the NP, a consortium of nanotoxicologists challenged the causal link with the symptoms (Donaldson et al., 2009) . Subsequent research with TEM identified silica NP in alveolar macrophages, epithelial cells, and chest fluid. The authors suggested that nanosilica particles were used as additive in the polyacrylic ester spraypainting process (Song et al., 2011) . Similarly, in the case of a 58-year-old man who died from a bronchiolitis obliterans organizing pneumonia after a 3-months exposure to polyester powder paint, the presence of titanium dioxide NPs in both pulmonary sample and the paint was demonstrated with TEM (Cheng et al., 2012) .
Submesothelial peritoneal deposition of carbon NP evidenced by electron microscopy and attributed to toner exposure has also been described, suggesting a possible systemic translocation after exposure by inhalation (Theegarten et al., 2010) . This translocation of carbon NP in humans can also be suspected in view of the black pigment found in the livers and spleens of coal workers in earlier studies, although electron microscopic confirmation of the finding is lacking (LeFevre et al., 1982) . Environmental exposures were also reported after the collapse of the World Trade Center. Seven patients followed up in the Mount Sinai World Trade Center medical monitoring program underwent lung biopsy during video-assisted thoracoscopy. CNT of various sizes and lengths were found in the lungs of four patients in concentrations ranging from 10 040 to 230 000 particles/g of wet lung. They were similar to those found in air samples (Wu et al., 2010) .
In these observations, presence of NP in tissues has been reported with electron microscopy although it was not always possible to conclude that there was a causal link with health effects. These sparse case reports highlight the need of an analysis of methods available to improve quantitative and qualitative characterization of NP in tissues.
WHICH TO OL S?
Biokinetic studies use high sensitivity and low background methods covering a range of several magnitudes (Kreyling et al., 2013) .The methods usually used in these studies are summarized in Fig. 1 . To be useful in clinical purposes, biological monitoring should be based on reproducible preparations and analytical protocols adapted to the range of size of NP using available and rapid tools.
In the first publications on the topic of biological monitoring of NP, the first stage of the diagnosis was to confirm the presence of NP in lung tissues and in fluids such as bronchoalveolar lavage fluid (BALF) or pleural liquid (Song et al., 2009; Phillips et al., 2010; Theegarten et al., 2010) although more evidence than this is required to be able to conclude in a causal link with the symptoms. Given its availability and its utilization by pathologists, electron microscopy was usually used for this purpose. Conventional optical microscopy is a quicker and more economical method but allows only the detection of aggregates because of a spatial resolution of 200 nm. Near field scanning optical microscopy with a spatial resolution sometimes under 50 nm (Amarie et al., 2012) is an interesting alternative but requires expensive equipment. These methods can be associated with other methods such as magnetic resonance imaging (MRI), computational tomography (CT) or positron emission tomography in multimodal or multifunctional imaging (Park et al., 2012) . Electron and scanning probe microscopes with resolutions in the sub-nanometer range are more suitable for the characterization and localization of NP in tissues. Moreover, analytical electron microscopy (energy dispersive X-ray spectroscopy or electron energy loss spectroscopy combined with TEM or SEM) allows the composition of elements heavier than beryllium to be determined. These high resolution methods are needed to characterize the size, distribution, shape, structure and chemical composition of nanomaterials especially in in vivo conditions for toxicological investigation (Bakand et al., 2012) . Their limitations are the following: the artifacts produced by the sample preparation needed to operate in a vacuum (Tiede et al., 2008) ; their lack of sensitivity making them inadequate for translocation studies in which NP concentrations in peripheral organs may be lower than one particle per 1 mm 2 section (Tsutsumi et al., 2011) ; and underestimation of size when the organic Perspectives in biological monitoring • 671 coating is not visualized (Choi et al., 2010) . Probably owing to these limitations, there is no published quantitative characterization method using SEM or TEM (Hagens et al., 2007) .
Thus, quantification of NP may be based on quantitative methods already used by pharmacological or toxicological hospital laboratories. These methods are based on elemental analysis of the tissue by methods such as instrumental neutron activation analysis, inductively coupled plasma with mass spectroscopy (ICPMS), or atomic emission spectroscopy (Khlebtsov et al., 2011) . These methods have several limitations: a possible natural background of the element under study (Kreyling et al., 2013) , possible loss or contamination during sample preparation and misinterpretation due to NP dissolution, with diffusion or accumulation of the ionized forms (Geiser et al., 2010) . Indeed, several NP are soluble in various physiological conditions (nanosilver, nanocopper, zinc and iron oxide NP, quantum dots) (Boyes et al., 2012) . Complex methods such as X-ray absorption spectroscopy are required to differentiate a particulate from an ionic form (Baek et al., 2012 ). An alternative is to use a separation method such as sedimentation field-flow fractionation (Deering et al., 2008) or hydrodynamic chromatography (Laborda et al., 2014) .
Moreover, standard elemental analysis of tissue does not provide any information on compartmental distribution (vascular, interstitial), which is crucial for tissue like the brain (De Jong et al., 2008; Boyes et al., 2012) . These data can be obtained by coupling elemental analysis with laser ablation (Wang et al., 2012; Koelmel et al., 2013) or with electron microscopy (Deng et al., 2007; Dziendzikowska et al., 2012) . A very promising method is single particle-ICPMS able to differentiate a particulate from an ionic form and to provide information on elemental chemical composition, size, number concentration, and size distribution of NP in liquid samples. At present it is suitable particularly for noncarbon NP consisting of one element and sizes higher than 20 nm of diameter (Laborda et al., 2014) . Single particle-ICPMS has been efficiently used to analyze silver, gold or titanium NP in digested tissues (van der Zande et al., 2012; Gray et al., 2013; Tassinari et al., 2014) .
Other indirect methods have been proposed such as medical imaging methods. CT had been used to indirectly identify NP that exhibit high atomic numbers and absorption coefficient (gold) or NP conjugated with contrast agents such as iodine (Roller et al., 2011) in human lung with a good spatial resolution. MRI had been also used to assess lung deposition of iron oxide NP (Carvalho et al., 2011) or to detect the metal impurities of CNT (Al Faraj et al., 2009) .
WHICH S A M PLE S?
Toxicokinetics studies are helpful to identify which biological fluid or tissue may be used in biometrology of NP.
In these studies, from 30 to 60% (Schmid et al., 2009) of inhaled NP are deposited in the nasopharyngeal, tracheobronchial and even alveolar regions (Geiser et al., 2010; Kreyling et al., 2013) . This deep deposition also demonstrated for aggregates like diesel exhaust particles (Broday et al., 2011) , implies a slower clearance and a higher probability of adverse health effects for NP (Bakand et al., 2012) .
After deposition, NP are cleared by chemical dissolution or physical translocation (Oberdörster et al., 2004) . In the alveolar region, phagocytic uptake by alveolar macrophages followed by dissolution or transport and accumulation in the lymphatic system lead to a half-life of 700 days in humans for micronic particles (Schmid et al., 2009 ). Owing to less effective recognition and internalization in phagocytic cells, this clearance is thought to be about 5 (Schmid et al., 2009 ) to 100-fold (Oberdörster et al., 2004) less efficient for NP. Translocation of particles from the alveolar space to the pleural space is possible, followed by lymphatic drainage through the stomata of the parietal pleura where particles may accumulate and form macroscopic structures known as black spots (Donaldson et al., 2010) .
In the tracheobronchial airways, NP are transported by mucociliary clearance towards the larynx and swallowed into the gastrointestinal tract. Penetration through the periciliary space and possible deposition in areas without mucus coverage may explain possible long-term retention (Kreyling et al., 2013) , resulting in their possible detection in BALF (Geiser et al., 2010) or in exhaled breath condensate. Such samples provide an interesting noninvasive method to detect and quantify NP in lung (Sauvain et al., 2014) .
After interstitial translocation, NP can pass through the endothelial cells and be detected in the blood (Oberdörster et al., 2004; Kreyling et al., 2013) . In blood, particles tend to be coated by different blood proteins promoting internalization (Kettiger et al., 2013) . Then they are rapidly (in a few minutes) cleared by the phagocytic cells of the mononuclear phagocyte system (MPS). Particles that are not captured by MPS cells can circulate longer and be carried out to the peripheral organs (Garnett et al., 2006) .
Intravenous administration studies have shown that major uptake occurs in the liver, followed by the spleen, lymph nodes and bone marrow, organs containing high levels of MPS cells and many other tissues in a smaller proportion such as lung, kidney, skin, and stomach.
Systemic translocation rate was found to be highly size-dependent (10-fold higher for 20 nm particles compared with 80 nm iridium particles, 40-fold higher for 1.4 nm gold particles compared with 18 nm) without a clear threshold and also depended on the agglomeration status of NP or their chemical composition (Geiser et al., 2010) . Translocation rate was found to be less than 5% for iridium particles (Geiser et al., 2010) and lower than 20% for 20 nm polystyrene particles (Sarlo et al., 2009 ). Schmid et al. estimated the total systemic accumulation of atmospheric ultrafine particles as 10 11 during the lifetime of a human, thus four orders of magnitude below the lung dose (Schmid et al., 2009) .
A few data are available in humans based on scintigraphic studies with technegas inhalation. Some authors reported systemic translocation with liver or bladder accumulation (Nemmar et al., 2002 ) whereas others did not, suggesting that positive results were at least to some extent related to the pertechnetate soluble fraction (Brown et al., 2002; Mills et al., 2006) . NP may also been detected in excreta like urine. Intravenous administration in rodents showed that urinary excretion following renal glomerular filtration
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may occur in NP with a hydrodynamic diameter lower than 6 nm (Choi et al., 2007; Li et al., 2008; Riviere et al., 2009; Boyes et al., 2012) . This threshold is probably not relevant for fibrous NP such as CNT (length up to 2.5 µm, diameter 20 nm) which were reported to be efficiently excreted in urine (Singh et al., 2006; Landsiedel et al., 2012) . Urinary excretion was also reported for spherical isolated or aggregated NP after respiratory exposure to 100 nm carbon particles (Wiebert et al., 2006) or 26 nm iron oxide particles (Zhu et al., 2009 ) and even after oral exposure to 25 or 80 nm zinc oxide (Lee et al., 2012) particles. It was impossible in these studies to rule out the possibility that a dissolved form was excreted.
Detection of NP, swallowed after mucociliary clearance or cleared from the blood by hepatobiliary excretion (Hagens et al., 2007; Oberdörster et al., 2009) in feces could be possible but would be hindered by the presence of dietary particles. Indeed, the estimated intake of dietary inorganic particles is about 40 mg/person/day, which corresponds to a daily ingestion of 10 12 -10 14 particles/ person (Powell et al., 2010) . Moreover, swallowed NP may also be absorbed in gastrointestinal tract. Intestinal uptake of NP is possible by absorption via enterocytes, paracellular uptake (persorption) and uptake by microfold cells of Peyer's patches into the lymphatic and blood circulation (O'Hagan et al., 1996; Oberdörster et al., 2004) . Reported uptake rates vary between 10 and 34% for particles under 100 nm, with great inter-individual variation (Fröhlich et al., 2012) .
In some studies, absence of fecal or urinary excretion was reported with a long-term accumulation confirmed for quantum dots (more than 133 days) or titanium dioxide NP (more than 182 days) (Landsiedel et al., 2012) .
Given these toxicokinetics data, inhaled NP might be detected in biological samples (BALF, exhaled condensate, blood, urine, feces) or in tissues (mainly in lung, pleura, liver, and spleen).
WH AT INITI A L DATA A R E AVA IL A BLE?
Once such particles have been identified and quantified, the clinician faces difficulties owing to the lack of reference values to interpret the data (Song et al., 2009) . This underlines the need for data obtained with validated methods in specific biological samples (BALF, lung tissue, etc.) and in relevant groups of exposures.
Extrapolation of experimental studies to humans Several interspecies differences have to be taken into account to extrapolate experimental results to humans, e.g. anatomical (monopodial branching structure and absence of respiratory bronchioles in rat) and physiological (rats are obligate nose breathers and have a higher lung clearance rate; Brown et al., 2005; Kreyling et al., 2006; Kreyling et al., 2013) . Moreover, laboratory inhalation and instillation studies do not efficiently simulate real-life exposure where complex mixtures in terms of size and chemical composition may affect deposition and clearance mechanisms (Brown et al., 2005) . Doses reached in experimental studies may be 100-to 1000-fold higher than doses in real exposure (Geiser et al., 2010) .
Applying the results of long-term kinetics studies in rats, Kreyling et al. estimated an accumulation of about 0.01-0.05% of each daily lung dose in the peripheral organs, corresponding to 4-20% of the daily deposited lung dose. Expressed as the number of particles, this means about 3 × 10 9 ultrafine particles deposited per day in the lung (3 × 10 11 during 1 year) and 1-6 × 10 8 ultrafine particles that would have accumulated in each secondary target organ corresponding to a mass lower than 10 ng (Kreyling et al., 2006) .
Other extrapolations suggest that approximately 5 × 10 12 atmospheric ultrafine particles are deposited daily in a human lung and 8 × 10 11 natural NP are absorbed orally (Kendall et al., 2012) .
Initial data on quantification of NP in human tissue
Although it is still unclear whether NP will be a public health concern, there is a crucial need to develop methods to quantify NP in the environment and in human tissues (Kendall et al., 2012) , and data are still sparse.
The burden of particles in the lung results from the equilibrium between deposition and clearance mechanisms (Oberdörster et al., 2004) . Owing to the very slow clearance kinetics in humans and the declining clearance rates as retention time increases, Geiser et al. estimated that about 10 to 20% of insoluble NP will never be cleared in physiological conditions and probably more in high exposure settings such as tobacco smoking or occupational exposures (Geiser et al., 2010) .
To date, very little is known about the lung burden of fine and ultrafine particles. Data are often limited to coarse fibrous or non-fibrous mineral particles involved in pneumoconiosis or lung cancer such as asbestos, silica and beryllium particles. Although the following publications are not restricted to NP, they provide some initial information on human lung content in NP. Environmental exposure to ultrafine particles is suggested by the presence of carbonaceous particles in macrophages of BALF in adults as revealed by analytical electron microscopy (Hauser et al., 2001) . The presence of the carbonaceous particles in alveolar macrophages obtained in children by sputum induction or BALF and assessed by optical microscopy has also been correlated with environmental exposure to ultrafine particles related to traffic pollution (Bunn et al., 2001 ) and industrial areas (Kalappanavar et al., 2012) , with an inverse, dose-dependent association with lung function parameters (Kulkarni et al., 2006) . Using SEM to assess lung sections from autopsies obtained during the 1952 London smog, Hunt et al. showed the presence of retained soot (ultrafine carbonaceous aggregates) and fine (<1 µm) metallic particles (Hunt et al., 2003) . Quantitative analyses were not performed especially because of the small volume analyzed and because of the low sensitivity for differentiating carbonaceous particles from carbonaceous tissues (Bunn et al., 2001 ). Churg et al. published several studies on the contents of autopsied lung in nonsmoker residents of a low polluted city (Vancouver) compared to a highly polluted city (Mexico City) using bleach digestion of samples and a combination of ultracentrifugation and filtration methods with TEM analysis. Although there was great inter-individual variability, they found both quantitative and qualitative differences. They found mean particle concentrations in Mexico City residents that were significantly higher than in residents of Vancouver (respectively 2.05 × 10 9 and 0.28 × 10 9 particles/g of dry lung). In the lung samples from Mexico City, 25% of particles were carbonaceous aggregates of ultrafine particles similar to the combustion-derived particles observed in air samples, whereas they were rarely observed in lungs in Vancouver. These authors surprisingly found a relative lack of accumulation of ultrafine particles compared with the published data of deposition, so they concluded that clearance was rapid (Churg et al., 1997; Churg et al., 2000; Brauer et al., 2001 ). Since several biases are possible, these results remain to be confirmed. However, future comparisons may prove to be difficult because of the lack a normalized method of sample preparation, counting rules, and particle classification. Moreover, in all these publications, results were expressed as numeric concentrations of NP although in experimental studies, biological effects like inflammation, histological effects, genotoxicity, and carcinogenicity are better correlated with dose expressed as surface area (Kendall et al., 2012) .
It remains unclear whether translocation may explain the extrapulmonary effects of NP. Indeed, adverse effects and translocation may also be due to water-soluble components of the particles, as shown for combustion-derived NP in rats (Wallenborn et al., 2007) . To date, there is no clear evidence of the presence of inhaled or ingested NP in human peripheral organs, contrary to evidence for coarse particles such as coal particles (Wu et al., 2010) , silica or asbestos fibers. Indeed, despite their length exceeding several microns, asbestos fibers have been found in several peripheral organs such as the kidney, heart, liver, spleen (Auerbach et al., 1980) and even in fetal lung, liver, muscle, and placental tissues (Haque et al., 1998) .
Microsized and nanosized particles of various compositions (metallic, ceramic material) have also been reported in blood and several tissues like liver, kidney, spleen, and fetal tissues by using SEM. However, in these publications, the lack of quantitative data and complete chemical characterization meant that it was not possible to draw conclusion about the sources of these particles (Gatti et al., 2004; Gatti et al., 2011) .
An overview of the publications related to NP identification and quantification in tissue or extrapulmonary translocation in human is presented in Table 1 .
CON CLUS ION
The intensive development of nanotechnology and NP-containing commercial products whose detrimental health effects are being increasingly suggested by experimental and epidemiologic studies is of great concern. In most first case report, clinicians may face difficulties because of the lack of a standardized method to analyze the NP content in tissues or to compare their results to reference values. The present review synthesizes published data concerning the potential usefulness of the biological monitoring of NP for clinical purposes. Toxicokinetic studies on NP suggest that they may preferentially enter by respiratory and oral routes with possible systemic translocation, leading to accumulation in the peripheral organs or excretion in feces or urine. These studies provide useful methods for the biological monitoring of NP both in terms of the retrospective evaluation of exposure and in the follow-up of occupational exposure in the workplace. Studies are now needed to assess the feasibility and relevance of quantifying NP in biological samples such as blood and urine for assessing occupational exposure, or in BALF or lung samples when NP are suspected of being responsible for lung disease. The biological monitoring of NP should be based on imaging methods such as electron microscopy, which are essential to confirm their presence and characterize their morphology and chemical composition in tissue. If quantitative data are required (ubiquitous particles), analytical quantitative methods such as inductively coupled plasma with atomic emission spectroscopy or ICPMS may complete these analyses. Single particle-ICPMS is also a promising method which allows to provide information on chemical and size characterization. There is an urgent need to develop standardized methods for the preparation and analysis of samples in order to quantify NP and define reference values. 
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